• ABSORB Japan interview with Ken Kozuma

    Dr. Ron Waksman interviews Dr. Ken Kozuma on the ABSORB Japan: 3-year clinical and angiographic results of a randomised trial evaluating the Absorb bioresorbable vascular scaffold vs. metallic DES in de novo native coronary artery lesions